PharScite

PharScite

Pharmaceutical Technology

  • Home
  • Services
  • Courses
  • Events
  • Blog
  • News
  • Contact

Direct-to-Consumer

Home Direct-to-Consumer

FDA Approves First Direct-to-Consumer Tests for Genetic Risk Information

By Sharif AhmedDiagnostics
The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA that provide information on an individual’s genetic predisposition to certain medical diseases or conditions, which…
1 Blue Hill Plaza, Suite 1509
Pearl River, New York 10965

Phone: +1 845-675-8540
Fax: +1 845-203-1495
Professional Development
Information Technology Solutions
Regulatory Services
Regulatory Insight
Regulatory Updates
Popular Courses
Upcoming Events

Subscribe to our RegLog and receive latest blog posts.
  • facebook
  • twitter
  • linkedin-square
  • instagram
  • youtube-play
Copyright © 2019 PharScite, LLC. All Right Reserved.
  • Terms
  • Privacy
  • Policy
  • Careers
✕
  • Home
  • Services
  • Courses
  • Events
  • Blog
  • News
  • Contact